References
- Kanner L. Autistic disturbances of affective contact. Nerv Child. 1943; 2: 237–50.
- Walker HB. A true case story. Microb Ecol Health Dis. 2012. doi: 10.3402/mehd.v23i0.18982.
- Bolte ER. Autism and Clostridium tetani. Med Hypotheses. 1998; 51: 133–44. 10.3402/mehd.v23i0.18982.
- Finegold SM, Molitoris D, Song Y, Vaisanen ML, Bolte E, McTeague M, et al. Gastrointestinal microflora studied in late-onset autism. Clin Infect Dis. 2002; 35: S6–16. 10.3402/mehd.v23i0.18982.
- Song Y, Molitoris DR, Tomzynski TJ, Lawson PA, Collins ND, Finegold SM. Clostridium bolteae sp. Nov., isolated from human sources. Syst Appl Microbiol. 2003; 26: 84–9. 10.3402/mehd.v23i0.18982.
- Finegold SM, Downwa J, Sumanen PH. Microbiology of regressive autism. Anaerobe. 2012; 2: 260–262. 10.3402/mehd.v23i0.18982.
- Williams BL, Homig M, Parekh T, Lipkin VM. Application of novel PR-based methods for detection, quantitation and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio. 2012; 3: 1–11. 10.3402/mehd.v23i0.18982.
- Benach JL, Li E, McGovern MM. A microbial association with autism. MBio. 2012; Feb 14 3(1). pii: e00019–12. doi: 10.3402/mehd.v23i0.18982.
- MacFabe DF. The role of enteric bacterial metabolites in mitochondrial dysfunction in autism – from animal models to human population. Microb Ecol Health Dis. doi: 10.3402/mehd.v23i0.18982.
- Pons R, Andru AL, Checcarelli N, Vila MR, Engelstad K, Sue SM, et al. Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr. 2004; 144: 81–5. 10.3402/mehd.v23i0.18982.
- Reichelt KL. Dietary derived, bioactive peptides in urine from autistic children. Microb Ecol Health Dis. 2012. doi: 10.3402/mehd.v23i0.18982.
- Ratajczak HV. Theoretical aspects of autism: biomarkers – a review. J Immunotoxicol. 2011; 8: 80–94. 10.3402/mehd.v23i0.18982.
- Wang L, Angley MT, Gerber JP, Sorich MJ. A review of candidate urinary biomarkers for autism spectrum disorder. Biomarkers. 2011; 16: 537–552. 10.3402/mehd.v23i0.18982.
- Clayton TA. Metabolic differences underlying two distinct rat urinary phenotypes, a putative role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS Lett. 2012; 586: 956–961.
- Ratajczak HV. Teoretical aspects of autism. Causes – a review. J Immunotoxicol. 2011; 8: 68–79. 10.3402/mehd.v23i0.18982.
- Christophersen OA. Should autism be considered a canary bird telling that Homo sapiens may be on its way to extinction?. Microb Ecol Health Dis. 2012. doi: 10.3402/mehd.v23i0.18982.
- Midtvedt T. Oxyquinoline derivatives – is one more dangerous than the others?. J Norw Med Assoc. 1971; 91: 1470–1480.
- Arbiser JL, Kraeft SK, van Leeuwen R, Hurwitz S, Selig M, Dickersin GR, et al. Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy. Mol Med. 1998; 10: 665–70.
- Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurogenerative disorders. CNS Neurosci Ther. 2012; 1: 41–6. 10.3402/mehd.v23i0.18982.
- Igata A. Clinical studies on rising and re-rising neurological diseases in Japan – a personal contribution. Proc Jpn Acad Sci Ser B Phys Biol Sci. 2010; 86: 366–77. 10.3402/mehd.v23i0.18982.
- Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012; 17: 389–401. 10.3402/mehd.v23i0.18982.
- De Fellice C, Signorini C, Durand T, Siccoli L, Leoncini S, D'Exposito M, et al. Partial rescue of Rett syndrome by omega-3 polyunsaturated fatty acids (PUFAs) oil. Genes Nutr. 2012; 7: 447–458. 10.3402/mehd.v23i0.18982.